Mix only the amount of powder you'll use in 28 days, and leave the rest as powder in the original vial until you need it
The regulatory shift The FDA removed tirzepatide from the drug shortage list in October 2024, which impacts the legal basis for compounding
Cardiologists, once peripheral to obesity management, now account for roughly one-third of new GLP-1 scripts, broadening the prescriber base
February 6, 2025: Lawsuits Against Rybelsus Manufacturer Novo Nordisk Increase 143 new lawsuits were filed related to injuries experienced after taking Rybelsus and other GLP-1 drugs
Kipnis says that overall, the side effects of the pill and injection are similar, with gastrointestinal (GI) events such as nausea being most common
Darsh Gosal, DO, Board-Certified Family Medicine Physician, is fully personalized to meet your unique needs and health goals